drugset / Trial / NCT05983328

Phase I Pharmacokinetic Study of HUYPS-1 in Healthy Volunteers

NCT05983328 ↗

Phase 1 Completed 14 enrolled Sinew Pharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

Fasting Period: At least 10 hours prior to dosing until 4 hours post-dose of each study period. Period: 24 hours post dose in each period. Each subject will complete two study periods. Washout Period: At least one week after dosing of the previous period. Confinement: From at least 10 hours prior to dosing until at least 12 hours post-dose, for a total of at least 22 hours for each study period.

Timeline

Start
2016-05-10
Primary completion
2016-05-26
Completion
2018-02-09

Drugs

EvaluationDrugModalityDoseRoute
Subject HUYPS-1 Unknown — Oral